WHO Pharmaceuticals Newsletter 1998, No. 03&04
(1998; 18 pages)
Table of Contents
Close this folderRegulatory actions
View the documentAluminium in total parenteral nutrition - labelling requirements & warning
View the documentAstemizole - warning concerning cardiovascular adverse events
View the documentBromfenac - warning label: liver damage
View the documentCarbamazepine - warning concerning precipitation
View the documentChlormezanone - withdrawn
View the documentCounterfeit drugs - warning to the public
View the documentDietary supplement "Sleeping Buddha" - warning concerning estazolam content
View the documentFenfluramine - withdrawn
View the documentHuman dura mater (freeze-dried) - restrictive measures
View the documentIsotretinoin - psychiatric adverse effects
View the documentPyrithione zinc (Skin-CapR) - withdrawn
View the documentSertindole - approval application withdrawn
View the documentTerfenadine - additional drug interactions
View the documentTerfenadine - withdrawn following approval of fexofenadine
Open this folder and view contentsDrug surveillance
Open this folder and view contentsNew developments
View the documentRecent approvals
Open this folder and view contentsMedical devices
Open this folder and view contentsGeneral information
Open this folder and view contentsVeterinary medicine
 

Counterfeit drugs - warning to the public

Dominican Republic. The Secretariat of State for Public Health and Social Assistance (SESPAS) has published an announcement in the national press warning the public about counterfeit medicines.

The Secretariat received a report that counterfeit and unapproved medicines were being sold to the population. It was informed by the Department of investigations of counterfeiting of the National Police that some medicines had been seized. Laboratory analysis showed that they contained the correct active ingredient but these products were believed to be counterfeit because the labelling did not correspond to the genuine product.

The general public are therefore recommended to check that the packaging of medicines contains the following information:

• name of laboratory
• number of registration
• lot number
• expiry date.

Pharmacists and Health Centres are urged to ensure that they acquire medicines only from authorized warehouses and distributors.

Reference: Public Announcement from the Secretariat of State for Public Health and Social Assistance, 14 March 1998.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018